Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Thomas M. Schiele"'
Autor:
Andreas König, Marcus Leibig, Volker Klauss, Hae-Young Sohn, Thomas M. Schiele, Florian Krötz, Johannes Rieber
Publikováno v:
Coronary Artery Disease. 22:188-193
BACKGROUND Late vessel failure by restenosis or thrombosis is a potential limitation of drug-eluting stent implantation. METHODS We conducted a prospective 5-year clinical evaluation following implantation of sirolimus-eluting Cypher stents for in-st
Autor:
Dieter Horstkotte, Thomas M. Schiele, Johannes Rieber, Hae-Young Sohn, Karl Theisen, Oliver Lindner, Marcus Wiemer, Volker Klauss, Andreas König, Marcus Leibig, Christoph Langer
Publikováno v:
EuroIntervention. 6:687-694
AIMS Recent trials with different designs indicated that drug-eluting stents may be superior to vascular brachytherapy (VBT) for the treatment of in-stent restenosis (ISR). We performed a randomised, double-centre, clinical, quantitative coronary ang
Autor:
Thomas M. Schiele
Publikováno v:
Vascular Disease Prevention. 4:281-295
Autor:
Johannes Rieber, Raffaella Matteucci Gothe, Volker Klauss, Uwe Siebert, Andreas König, Bruno Reichart, Thomas M. Schiele, E Kilian, Hae-Young Sohn
Publikováno v:
The Journal of Heart and Lung Transplantation. 27:302-309
Background The survival of heart transplant patients is limited by cardiac allograft vasculopathy (CAV). Intravascular ultrasound (IVUS) and IVUS-derived radiofrequency plaque composition analysis (IVUS-RF) provide further information about the proce
Autor:
Johannes Rieber, Uwe Siebert, Karl Theisen, Thomas M. Schiele, Andreas König, Volker Klauss, Marcus Leibig, Isabelle Erhard
Publikováno v:
American Heart Journal. 150:351-357
Background The aim of the study was to compare the angioplasty mechanisms of drug (sirolimus)-eluting stent (DES) implantation and vascular brachytherapy (VBT) for the treatment of in-stent restenosis (ISR) as assessed by intravascular ultrasound (IV
Autor:
Thomas M. Schiele, Monika Baylacher, Volker Klauss, Hans-Ulrich Stempfle, Andreas König, Uwe Siebert, Karl Theisen, M. Hacker, Johannes Rieber, Philip Jung, Isabelle Erhard
Publikováno v:
Zeitschrift für Kardiologie. 94:321-327
Fractional flow reserve (FFR) is a new but well established parameter for the hemodynamic evaluation of coronary stenoses. A FFR below 0.75 was validated as functionally significant in coronary one or two vessel disease. This study was designed to pr
Publikováno v:
Current Pharmaceutical Design. 11:421-433
In-stent restenosis remains the limitation of coronary stent implantation despite numerous efforts of its prevention by catheter-based techniques or by drug therapy. Today, only intravascular irradiation has proven to effectively reduce neointima for
Autor:
M. C. Haufe, Johannes Rieber, Thomas M. Schiele, Karl Theisen, Andreas König, Volker Klauss, Hans-Ulrich Stempfle, M. Leibig, Uwe Siebert, Monika Baylacher, Gaby Sroczynski, Petra Erdin
Publikováno v:
Heart. 91:203-206
To determine the prognostic value of fractional flow reserve (FFR) measurements after coronary stent implantation including multiple clinical and angiographic parameters collected in one centre.119 consecutive patients were enrolled who had a stent i
Publikováno v:
Journal of Vascular Research. 42:312-324
Selective inhibitors of cyclooxygenase-2 (COX-2, ‘coxibs’) are highly effective anti-inflammatory and analgesic drugs that exert their action by preventing the formation of prostanoids. Recently some coxibs, which were designed to exploit the adv
Autor:
Thomas M. Schiele, Gianni Casella, Andreas König, Petra Erdin, Volker Klauss, Hans-Ulrich Stempfle, Johannes Rieber, Uwe Siebert, Marcus Leibig, Reiner Schrepf, Victoria Seelig
Publikováno v:
American Heart Journal. 148:590-595
Achievement of maximal hyperemia of the coronary microcirculation is a prerequisite for the measurement of fractional flow reserve (FFR). Intravenous adenosine is considered the standard method, but its use in the catheterization laboratory is time c